Navigation Links
ADVENTRX in Medical News

ADVENTRX Pharmaceuticals Announces Closing of Financing

... SAN DIEGO, July 6 /PRNewswire-FirstCall/ -- adventrx Pharmaceuticals, Inc. (NYSE Amex: ANX ) announce...ck is converted at any time prior to July 6, 2014, adventrx will pay the holder an amount equal to the total d...such converted convertible preferred shares. adventrx plans to use the net proceeds from the offering to...

ADVENTRX Grants Exclusive Rights to ANX-514 in South Korea

... SAN DIEGO, March 25 /PRNewswire-FirstCall/ -- adventrx Pharmaceuticals, Inc. (NYSE Amex: ANX ) announce...t candidates. Under the terms of their agreement, adventrx will receive an upfront cash payment of $300,000, ... "We are delighted at the opportunity to work with adventrx and foresee substantial market potential for ANX-5...

ADVENTRX Pharmaceuticals to Report Third Quarter 2008 Results

...om SAN DIEGO, Oct. 30 /PRNewswire-FirstCall/ -- adventrx Pharmaceuticals, Inc. (Amex: ANX ) today announce...3-1112 and entering the pass code 1669546. About adventrx Pharmaceuticals adventrx Pharmaceuticals is a biopharmaceutical company foc...

ADVENTRX Pharmaceuticals Reports Second Quarter 2008 Financial Results and Business Update

...om SAN DIEGO, Aug. 11 /PRNewswire-FirstCall/ -- adventrx Pharmaceuticals, Inc. (Amex: ANX ), a biopharmace... of June 30, 2008. Conference Call and Webcast adventrx management will host a conference call with simult...3-1112 and entering the pass code 8240633. About adventrx Pharmaceuticals ...

ADVENTRX Pharmaceuticals to Report First Quarter 2008 Results

....com SAN DIEGO, May 5 /PRNewswire-FirstCall/ -- adventrx Pharmaceuticals, Inc. (Amex: ANX ) today announce...03-1112 and entering the passcode 5439297. About adventrx Pharmaceuticals adventrx Pharmaceuticals is a biopharmaceutical company foc...

QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes

...Laboratories (Nasdaq: IDXX ) Add Bruker Corporation (Nasdaq: BRKR ) Halozyme Therapeutic (Nasdaq: HALO ) Emerging Cancer Index (HHJ) Drop adventrx Pharmaceuticals, Inc. (Amex: ANX ) Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ) Add Dyanvax Technologies (Nasdaq: DVAX ) Synta Pharmaceuti...

ADVENTRX Pharmaceuticals to Present at The 10th Annual BIO CEO & Investor Conference

... SAN DIEGO, Feb. 5 /PRNewswire-FirstCall/ -- adventrx Pharmaceuticals, Inc. (Amex: ANX ), a biopharmace...and can be accessed through the same link. About adventrx Pharmaceuticals adventrx Pharmaceuticals is a biopharmaceutical research an...

ADVENTRX Pharmaceuticals to Present at the 2007 RBC Capital Markets Healthcare Conference

... SAN DIEGO, Dec. 10 /PRNewswire-FirstCall/ -- adventrx Pharmaceuticals, Inc. (Amex: ANX ), a biopharmace...and can be accessed through the same link. About adventrx Pharmaceuticals adventrx Pharmaceuticals is a biopharmaceutical research an...

ADVENTRX Pharmaceuticals to Present at the 13th Annual BIO-Europe Partnering Conference

... SAN DIEGO, Nov. 5 /PRNewswire-FirstCall/ -- adventrx Pharmaceuticals, Inc. (Amex: ANX ), a biopharmace... drive their business successfully forward. About adventrx Pharmaceuticals adventrx Pharmaceuticals is a biopharmaceutical research an...

ADVENTRX Pharmaceuticals to Present at the 18th Annual CIBC Healthcare Conference

... SAN DIEGO, Oct. 31 /PRNewswire-FirstCall/ -- adventrx Pharmaceuticals, Inc. (Amex: ANX ), a biopharmace... and can be accessed through the same link. About adventrx Pharmaceuticals adventrx Pharmaceuticals is a biopharmaceutical research an...
ADVENTRX in Medical Technology

ADVENTRX Announces Results From ANX-514 Bioequivalence Study

...ss SAN DIEGO, May 7 /PRNewswire-FirstCall/ -- adventrx Pharmaceuticals, Inc. (NYSE Amex: ANX ) today an...te, gastric and head and neck cancers. About adventrx Pharmaceuticals adventrx Pharmaceuticals is a biopharmaceutical company who...

ADVENTRX Completes Patient Enrollment in ANX-514 Bioequivalence Study

... SAN DIEGO, Feb. 5 /PRNewswire-FirstCall/ -- adventrx Pharmaceuticals, Inc. (NYSE Alternext US: ANX), an...e, gastric and head and neck cancers. About adventrx Pharmaceuticals adventrx Pharmaceuticals is a biopharmaceutical company foc...

ADVENTRX Announces Preliminary Response Rate Data From Discontinued Phase 3 Trial of CoFactor(R)

... SAN DIEGO, July 1 /PRNewswire-FirstCall/ -- adventrx Pharmaceuticals, Inc. (Amex: ANX ) today announce...ly allowing 5-FU to work more effectively. About adventrx Pharmaceuticals adventrx Pharmaceuticals is a biopharmaceutical company foc...

ADVENTRX Announces CoFactor(R) Phase 2b Clinical Trial Overall Survival Results

... SAN DIEGO, June 16 /PRNewswire-FirstCall/ -- adventrx Pharmaceuticals, Inc. (Amex: ANX ) today provided...ly allowing 5-FU to work more effectively. About adventrx Pharmaceuticals adventrx Pharmaceuticals is a biopharmaceutical company foc...

ADVENTRX Presents CoFactor Data at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO)

... SAN DIEGO, June 3 /PRNewswire-FirstCall/ -- adventrx Pharmaceuticals, Inc. (Amex: ANX ) announced toda...ly allowing 5-FU to work more effectively. About adventrx Pharmaceuticals adventrx Pharmaceuticals is a biopharmaceutical company foc...

ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study

...logy SAN DIEGO, May 16 /PRNewswire-FirstCall/ -- adventrx Pharmaceuticals, Inc. (Amex: ANX ) announced toda...udy, was observed between ANX-530 and Navelbine. adventrx intends to submit to the U.S. Food and Drug Admini...ssociated with administration of the drug. About adventrx Pharmaceuticals ...

ANX-201 Demonstrates a Unique Resistance Profile in Preclinical Tests

... adventrx Presents Results at Keystone Symposia HIV Pathogen...ce SAN DIEGO, March 31 /PRNewswire-FirstCall/ -- adventrx Pharmaceuticals, Inc. (Amex: ANX ) announced that...simplex viruses 1 and 2 (HSV-1 and HSV-2). About adventrx Pharmaceuticals ...

ADVENTRX to Present CoFactor Phase 2 Breast Cancer Data at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO)

... SAN DIEGO, March 12 /PRNewswire-FirstCall/ -- adventrx Pharmaceuticals, Inc. (Amex: ANX ) announced toda...ly allowing 5-FU to work more effectively. About adventrx Pharmaceuticals adventrx Pharmaceuticals is a biopharmaceutical company foc...

ADVENTRX to Present ANX-201 Preclinical Data at Keystone Symposia HIV Pathogenesis Conference

... SAN DIEGO, Jan. 31 /PRNewswire-FirstCall/ -- adventrx Pharmaceuticals, Inc. (Amex: ANX ), announced tod...simplex viruses 1 and 2 (HSV-1 and HSV-2). About adventrx Pharmaceuticals adventrx Pharmaceuticals is a biopharmaceutical research an...

ADVENTRX Announces Completion of Patient Enrollment in Phase 2 Clinical Trial of CoFactor(R) for the Treatment of Advanced Breast Cancer

... SAN DIEGO, Dec. 5 /PRNewswire-FirstCall/ -- adventrx Pharmaceuticals, Inc. (Amex: ANX ), a biopharmace... 5-FU to work more effectively. In October 2007, adventrx announced the results from its Phase 2b clinical t...rd to either efficacy or safety. In November 2007, adventrx announced that it would discontinue enrolling pati...
ADVENTRX in Biological Technology

Eric K. Rowinsky Joins ADVENTRX Board of Directors

SAN DIEGO, Feb. 25 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (Amex: ANX ) announced today that Eric K. Rowinsky, M.D., Chief Medical Officer and Executive Vice President of ImClone Systems Incorporated, will join its Board of Directors. In connection with Dr. Rowinsky's appoint...

ADVENTRX to Hold Second Quarter Results and Business Update Conference Call on August 12

... SAN DIEGO, Aug. 5 /PRNewswire-FirstCall/ -- adventrx Pharmaceuticals, Inc. (NYSE Amex: ANX ) today an...ng the completion of the call. About adventrx adventrx Pharmaceuticals is a biopharmaceutical company who...

ADVENTRX Pharmaceuticals Announces Financing

... SAN DIEGO, Aug. 5 /PRNewswire-FirstCall/ -- adventrx Pharmaceuticals, Inc. (NYSE Amex: ANX ) announce... converted at any time prior to February 10, 2012, adventrx will pay the holder an amount equal to the total d... the satisfaction of customary closing conditions. adventrx plans to use the net proceeds from the offering to...

ADVENTRX Pharmaceuticals Announces Plans for Remainder of 2009

... SAN DIEGO, June 29 /PRNewswire-FirstCall/ -- adventrx Pharmaceuticals, Inc. (NYSE Amex: ANX ) today an...wing the financing that closed earlier this month, adventrx has re-started the final manufacturing activities ...ntinued availability of capital for companies like adventrx with late-stage product candidates. However, we w...

ADVENTRX Pharmaceuticals Announces Closing of Financing

... SAN DIEGO, June 15 /PRNewswire-FirstCall/ -- adventrx Pharmaceuticals, Inc. (NYSE Amex: ANX ) today an...e fifth anniversary of such initial exercise date. adventrx plans to use the net proceeds from the offering to...xpenses. The shares and warrants were sold by adventrx pursuant to an effective shelf registration statem...

ADVENTRX Pharmaceuticals Announces Financing

... SAN DIEGO, June 8 /PRNewswire-FirstCall/ -- adventrx Pharmaceuticals, Inc. (NYSE Amex: ANX ) announce... the satisfaction of customary closing conditions. adventrx plans to use the net proceeds from the offering to... The shares and warrants are being offered by adventrx pursuant to an effective shelf registration statem...

ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results

... SAN DIEGO, March 25 /PRNewswire-FirstCall/ -- adventrx Pharmaceuticals, Inc. (NYSE Amex: ANX ) today re...ber 31, 2008. "2008 was a transition year for adventrx in which we advanced a new business model focused ...ptember 30, 2008 should no longer be relied upon. adventrx intends to correct the misstatements in those fina...

ADVENTRX Announces Further Cost-Cutting Measures

... SAN DIEGO, March 20 /PRNewswire-FirstCall/ -- adventrx Pharmaceuticals, Inc. (NYSE Amex: ANX ) announce...y, ADVENTRX's Chief Business Officer. About adventrx Pharmaceuticals adventrx Pharmaceuticals is a biopharmaceutical company who...

ADVENTRX Provides Update on Strategic Transaction Process

... SAN DIEGO, Feb. 10 /PRNewswire-FirstCall/ -- adventrx Pharmaceuticals, Inc. (NYSE Alternext US: ANX) ann...dvanced or metastatic breast cancer. About adventrx Pharmaceuticals adventrx Pharmaceuticals is a biopharmaceutical company foc...

ADVENTRX Announces Further Cost-Cutting Measures

...e SAN DIEGO, Jan. 5 /PRNewswire-FirstCall/ -- adventrx Pharmaceuticals, Inc. (NYSE Alternext US: ANX) ann...rtner or partners," stated Jack Lief, Chair of the adventrx Board of Directors. "Mark's willingness to join t...g discussions." Strategic Opportunities adventrx is seeking partners for one or both of its two lat...
Other Tags
(Date:12/19/2014)... These vanadium reserves are mostly found ... 151,000 tons of vanadium were produced globally in 2013, ... increased at 6.7% AAGR during the period from 2001 ... being the largest consumer, accounted for more than 90% ... alloy and the chemical industry. , View Full Report ...
(Date:12/19/2014)... Dec. 19, 2014 (HealthDay News) -- New research warns parents that ... lives at risk. Nearly half of teen drivers killed in ... were at least 11 years old and often lacked important safety ... Eighty-two percent of teen drivers killed in crashes were in cars ... to 10 years old, 31 percent were in cars 11 to ...
(Date:12/19/2014)... FRIDAY, Dec. 19, 2014 (HealthDay News) -- Injectable drug ... double the suicide attempt rate of other substance users, ... use is associated with the risk of suicide attempt ... the University of Montreal, said in a university news ... users. We wanted to know who among substance users ...
(Date:12/19/2014)... NC (PRWEB) December 19, 2014 Surviving Mesothelioma ... and EPA information indicates that these pipes can leach asbestos ... go to the full story on the Surviving Mesothelioma ... the erosion of natural asbestos deposits, decaying water mains made ... drinking water. , To protect consumers from mesothelioma ...
(Date:12/19/2014)... (PRWEB) December 19, 2014 B. E. ... to healthcare providers, has been retained to lead a ... Memorial Hospital in Franklin, Ind. The top executive search ... recently placed more than 900 healthcare executives into organizations. ... full service hospital providing care to the residents of ...
Breaking Medicine News(10 mins):Health News:Marketresearchreports.biz: Global Vanadium Usage Increased at AAGR of 6.7% between 2001 and 2013 2Health News:Marketresearchreports.biz: Global Vanadium Usage Increased at AAGR of 6.7% between 2001 and 2013 3Health News:Older Cars a Bad Choice for Younger Drivers 2Health News:Cocaine, Amphetamines May Up Injection Drug Users' Suicide Risk 2Health News:Surviving Mesothelioma Warns of Potential Mesothelioma Risk from Cement Water Pipes 2Health News:Johnson Memorial Hospital Retains B. E. Smith to Recruit New Chief Financial Officer 2Health News:Johnson Memorial Hospital Retains B. E. Smith to Recruit New Chief Financial Officer 3
(Date:12/17/2014)... NEW YORK , Dec. 15, 2014 /PRNewswire-USNewswire/ ... a Good Clinical Practices (GCP) audit to confirm ... Administration (FDA) regulations. This accomplishment enables HITLAB to ... trials utilizing the highest principles for patient safety ... to improve global healthcare access, quality, and delivery ...
(Date:12/15/2014)... Research and Markets ( http://www.researchandmarkets.com/research/87pph8/global_facial ... "Global Facial Recognition Market 2015-2019" report to ... Facial recognition is a technology ... system measures the overall facial feature of a ... the distance between eyes. Facial recognition is used ...
(Date:12/11/2014)... Dec. 10, 2014  Data Sciences International (DSI), ... released a new series of digital telemetry implants ... researchers. M series, part of the PhysioTel™ Digital ... best possible physiologic data when incorporating functional endpoints ... endpoints to toxicology studies has evolved from short ...
Breaking Biology News(10 mins):HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3New telemetry implants expected to change how large animal toxicology studies are conducted 2
Other Contents